Evidence map›Paper›PMID 42194983›Full record

ArticleGenes2026

Transcriptomic Insights into the Association of IL-1 Signaling with the Senescence-Associated Secretory Phenotype in Human Fibroblasts.

Vural Yilmaz

Abstract read
In one paragraph

Article in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Vural YilmazBiotechnology Research Center (BRC), Cyprus International University (CIU), Via Mersin 10, Nicosia 99258, Northern Cyprus, Türkiye.ORCID 0000-0002-1959-6778

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesCellular senescence is a stable growth-arrested state accompanied by the senescence-associated secretory phenotype (SASP), a complex inflammatory secretome that contributes to tissue remodeling, chronic inflammation, and age-related disease. Although multiple signaling pathways have been implicated in SASP regulation, the extent to which interleukin-1 (IL-1) signaling is associated with the organization of SASP-associated transcriptional programs remains incompletely defined at the transcriptomic level.

methodsHere, we performed a focused in silico analysis of a publicly available RNA-sequencing dataset (GSE63577) profiling primary human fibroblasts undergoing replicative senescence. Differential expression analysis revealed broad inflammatory remodeling in senescent fibroblasts, including robust upregulation of canonical SASP-associated cytokines, chemokines, and matrix-related factors. Targeted visualization using a curated, literature-defined SASP gene panel confirmed consistent transcriptional activation of key SASP components during replicative senescence.

resultsTo assess transcriptional associations, we performed correlation-based network analysis centered on

conclusionsTogether, these findings suggest that IL-1 signaling is consistently associated with a central position within the SASP-associated transcriptional network during replicative senescence in human fibroblasts. Therefore, the present study contributes transcriptomic network-level evidence supporting an association between IL-1 signaling and coordinated SASP-associated inflammatory programs, and highlights its potential relevance for intervention strategies.

Indexed as

Cellular SenescenceFibroblastsInterleukin-1Interleukin-1betaSenescence-Associated Secretory PhenotypeTranscriptomeCells, CulturedGene Expression ProfilingGene Expression RegulationHumansInterleukin-1alphaSignal TransductionIL1A protein, humanInterleukin-1Interleukin-1alphaInterleukin-1betacellular senescenceinterleukin-1 signalingreplicative senescencesenescence-associated secretory phenotypetranscriptomic network analysis

Identifiers

PMID42194983
PMCPMC13205888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.